Underlying mechanism for suppression of vascular smooth muscle cells by green tea polyphenol EGCG released from biodegradable polymers for stent application

Journal of Biomedical Materials Research - Part A

Volumn 95 A, Issue 2, 2010, Pages 424-433

  Han, Dong Wook ^a   Jung, Duk Young ^b   Park, Jong Chul ^c   Cho, Han Hee ^d   Hyon, Suong Hyu ^d   Han, Dong Keun ^e  

^a Pusan National University   (South Korea)

^b Senior Products Industrial Center   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d KYOTO UNIVERSITY   (Japan)

^e Korea Institute of Science and Technology   (South Korea)

Author keywords

epigallocatechin 3 O gallate; phosphorylated Akt; phosphorylated nuclear factor I B; poly(lactide co caprolactone); vascular smooth muscle cells

Indexed keywords

APOPTOSIS; BENEFICIAL EFFECTS; CAPROLACTONE; CELL-CYCLE ARREST; CELL-CYCLE PROGRESSION; CELLULAR RESPONSE; FLUORESCEIN ISOTHIOCYANATE; GALLATE; GREEN TEA POLYPHENOLS; L-LACTIDE; LACTIDES; MATRIX METALLOPROTEINASE-2; NUCLEAR FACTORS; NUCLEAR TRANSLOCATIONS; PHOSPHORYLATED AKT; TARGET GENES; UNDERLYING MECHANISM; VASCULAR SMOOTH MUSCLE CELLS;

BIODEGRADABLE POLYMERS; BLOOD VESSEL PROSTHESES; CELL DEATH; GENES; MUSCLE; ORGANIC POLYMERS; PHENOLS; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

CELL CULTURE;

EPIGALLOCATECHIN GALLATE; FLUORESCEIN ISOTHIOCYANATE; GELATINASE A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; POLYCAPROLACTONE; PROTEIN KINASE B; TEAVIGO; UNCLASSIFIED DRUG;

ANIMAL CELL; AORTA; APOPTOSIS; ARTICLE; BIODEGRADABILITY; BIOFILM; CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; DOG; DRUG CONJUGATION; DRUG RELEASE; ENZYME INACTIVATION; GENE TARGETING; INTERNALIZATION; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SMOOTH MUSCLE FIBER; STENT; TEA; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTIOXIDANTS; AORTA; APOPTOSIS; BIOCOMPATIBLE MATERIALS; CATECHIN; CELL ADHESION; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; DOGS; MALE; MATERIALS TESTING; MATRIX METALLOPROTEINASE 2; MOLECULAR STRUCTURE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NF-KAPPA B; POLYMERS; PROTO-ONCOGENE PROTEINS C-AKT; STENTS;

EID: 78649282452     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32870     Document Type: Article

References (43)

1. Pektok E, Nottelet B, Tille JC, Gurny R, Kalangos A, Moeller M, Walpoth BH,. Degradation and healing characteristics of small-diameter poly(ε-caprolactone) vascular grafts in the rat systemic arterial circulation. Circulation 2008; 118: 2563-2570.
2. Prabhu S, Hossainy S,. Modeling of degradation and drug release from a biodegradable stent coating. J Biomed Mater Res A 2007; 80: 732-741.
3. Dzau VJ, Braun-Dullaeus RC, Sedding DG,. Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies. Nat Med 2002; 8: 1249-1256.
4. Moon SK, Kang SK, Kim CH,. Reactive oxygen species mediates disialoganglioside GD3-induced inhibition of ERK1/2 and matrix metalloproteinase-9 expression in vascular smooth muscle cells. FASEB J 2006; 20: 1387-1395.
5. Ginnan R, Guikema BJ, Halligan KE, Singer HA, Jourd'heuil D,. Regulation of smooth muscle by inducible nitric oxide synthase and NADPH oxidase in vascular proliferative diseases. Free Radic Biol Med 2008; 44: 1232-1245.
6. Galis ZS, Khatri JJ,. Matrix metalloproteinases in vascular remodeling and atherogenesis: The good, the bad, and the ugly. Circ Res 2002; 90: 251-262.
7. Na H-K, Surh Y-J,. Intracellular signaling network as a prime chemopreventive target of (-)-epigallocatechin gallate. Mol Nutr Food Res 2006; 50: 152-159.
8. Stangl V, Dreger H, Stangl K, Lorenz M,. Molecular targets of tea polyphenols in the cardiovascular system. Cardiovasc Res 2007; 73: 348-358.
9. Tipoe GL, Leung TM, Hung MW, Fung ML,. Green tea polyphenols as an anti-oxidant and anti-inflammatory agent for cardiovascular protection. Cardiovasc Hematol Disord Drug Target 2007; 7: 135-144.
10. Cho HH, Han D-W, Matsumura K, Tsutsumi S, Hyon S-H,. The behavior of vascular smooth muscle cells and platelets onto epigallocatechin gallate-releasing poly(L -lactide-co-ε-caprolactone) as stent-coating materials. Biomaterials 2008; 29: 884-893.
11. Han D-W, Lim HR, Baek HS, Lee MH, Lee SJ, Hyon S-H, Park J-C,. Inhibitory effects of epigallocatechin-3-O-gallate on serum-stimulated rat aortic smooth muscle cells via nuclear factor-IκB down-modulation. Biochem Biophys Res Commun 2006; 345: 148-155.
12. Han D-W, Matsumura K, Kim B, Hyon S-H,. Time-dependent intracellular trafficking of FITC-conjugated epigallocatechin-3-O-gallate in L-929 cells. Bioorg Med Chem 2008; 16: 9652-9659.
13. Minion DJ, van de Kerkhove MP, Goodman GR, van Aalst JA, Absood A, Fox PL, Graham LM,. The proliferative response to platelet-derived growth factor of smooth muscle cells isolated from synthetic vascular grafts in a canine model. J Vasc Surg 1999; 29: 845-850.
14. Tamai H, Igaki K, Kyo E, Kosuga K, Kawashima A, Matsui S, Komori H, Tsuji T, Motohara S, Uehata H,. Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans. Circulation 2000; 102: 399-404.
15. Pan CJ, Shao ZY, Tang JJ, Wang J, Huang N,. In vitro studies of platelet adhesion, activation, and protein adsorption on curcumin-eluting biodegradable stent materials. J Biomed Mater Res A 2007; 82: 740-746.
16. Lao LL, Venkatraman SS,. Paclitaxel release from single and double-layered poly(DL -lactide-co-glycolide)/poly(L -lactide) film for biodegradable coronary stent application. J Biomed Mater Res A 2008; 87: 1-7.
17. Chen MC, Chang Y, Liu CT, Lai WY, Peng SF, Hung YW, Tsai HW, Sung HW,. The characteristics and in vivo suppression of neointimal formation with sirolimus-eluting polymeric stents. Biomaterials 2009; 30: 79-88.
18. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehran R, Leon MB,. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007; 356: 998-1008.
19. Prunotto M, Vignolini C, Lolli V, Black A, Gaggianesi S, Santarelli A, Galloni M,. Short-, mid-, and long-term effects of a polymer-free tacrolimus-eluting stent in a porcine coronary model. J Biomed Mater Res A 2009; 88: 872-879.
20. Hofmann CS, Sonenshein GE,. Green tea polyphenol epigallocatechin-3 gallate induces apoptosis of proliferating vascular smooth muscle cells via activation of p53. FASEB J 2003; 17: 702-704.
21. Cheng XW, Kuzuya M, Nakamura K, Liu Z, Di Q, Hasegawa J, Iwata M, Murohara T, Yokota M, Iguchi A,. Mechanisms of the inhibitory effect of epigallocatechin-3-gallate on cultured human vascular smooth muscle cell invasion. Arterioscler Thromb Vasc Biol 2005; 25: 1864-1870.
22. 2 production, and maintaining calcium-ATPase activity. J Cardiovasc Pharmacol 2008; 51: 45-54.
23. Galis ZS, Khatri JJ,. Matrix metalloproteinases in vascular remodeling and atherogenesis: The good, the bad, and the ugly. Circ Res 2002; 90: 251-262.
24. Huang Y, Mironova M, Lopes-Virella MF,. Oxidized LDL stimulates matrix metalloproteinase-1 expression in human vascular endothelial cells. Arterioscler Thromb Vasc Biol 1999; 19: 2640-2647.
25. Isemura M, Saeki K, Kimura T, Hayakawa S, Minami T, Sazuka M,. Tea catechins and related polyphenols as anti-cancer agents. Biofactors 2000; 13: 81-85.
26. Sachinidis A, Skach RA, Seul C, Ko Y, Hescheler J, Ahn H-Y, Fingerle J,. Inhibition of the PDGF β-receptor tyrosine phosphorylation and its downstream intracellular signal transduction pathway in rat and human vascular smooth muscle cells by different catechins. FASEB J 2002; 16: 893-895.
27. Rodriguez SK, Guo W, Liu L, Band MA, Paulson EK, Meydani M,. Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex. Int J Cancer 2006; 118: 1635-1644.
28. Mehrhof FB, Schmidt-Ullrich R, Dietz R, Scheidereit C,. Regulation of vascular smooth muscle cell proliferation: Role of NF-IκB revisited. Circ Res 2005; 96: 958-964.
29. Peng CY, Pan SL, Huang YW, Guh JH, Chang YL, Teng CM,. Baicalein attenuates intimal hyperplasia after rat carotid balloon injury through arresting cell-cycle progression and inhibiting ERK, Akt, and NF-IκB activity in vascular smooth-muscle cells. Naunyn Schmiedebergs Arch Pharmacol 2008; 378: 579-588.
30. Romashkova JA, Makarov SS,. NF-IκB is a target of AKT in anti-apoptotic PDGF signaling. Nature 1999; 401: 86-90.
31. Hastak K, Gupta S, Ahmad N, Agarwal MK, Agarwal ML, Mukhtar H,. Role of p53 and NF-IκB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells. Oncogene 2003; 22: 4851-4859.
32. Chong ZZ, Kang JQ, Maiese K,. Essential cellular regulatory elements of oxidative stress in early and late phases of apoptosis in the central nervous system. Antioxid Redox Signal 2004; 6: 277-287.
33. Calabro P, Samudio I, Willerson JT, Yeh ET,. Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways. Circulation 2004; 110: 3335-3340.
34. Yin Z, Henry EC, Gasiewicz TA,. (-)-Epigallocatechin-3-gallate is a novel Hsp90 inhibitor. Biochemistry 2009; 48: 336-345.
35. Won SM, Park YH, Kim HJ, Park KM, Lee WJ,. Catechins inhibit angiotensin II-induced vascular smooth muscle cell proliferation via mitogen-activated protein kinase pathway. Exp Mol Med 2006; 38: 525-534.
36. Lo HM, Hung CF, Huang YY, Wu WB,. Tea polyphenols inhibit rat vascular smooth muscle cell adhesion and migration on collagen and laminin via interference with cell-ECM interaction. J Biomed Sci 2007; 14: 637-645.
37. Uekusa Y, Kamihira M, Nakayama T,. Dynamic behavior of tea catechins interacting with lipid membranes as determined by NMR spectroscopy. J Agric Food Chem 2007; 55: 9986-9992.
38. Palermo CM, Westlake CA, Gasiewicz TA,. Epigallocatechin gallate inhibits aryl hydrocarbon receptor gene transcription through an indirect mechanism involving binding to a 90 kDa heat shock protein. Biochemistry 2005; 44: 5041-5052.
39. Okabe S, Suganuma M, Hayashi M, Sueoka E, Komori A, Fujiki H,. Mechanisms of growth inhibition of human lung cancer cell line, PC-9, by tea polyphenols. Jpn J Cancer Res 1997; 88: 639-643.
40. Hong J, Lu H, Meng X, Ryu JH, Hara Y, Yang CS,. Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin-3- gallate in HT-29 human colon adenocarcinoma cells. Cancer Res 2002; 62: 7241-7246.
41. Tachibana H, Koga K, Fujimura Y, Yamada K,. A receptor for green tea polyphenol EGCG. Nat Struct Mol Biol 2004; 11: 380-381.
42. Umeda D, Yano S, Yamada K, Tachibana H,. Green tea polyphenol epigallocatechin-3-gallate signaling pathway through 67-kDa laminin receptor. J Biol Chem 2008; 283: 3050-3058.
43. Kuzuhara T, Sei Y, Yamaguchi K, Suganuma M, Fujiki H,. DNA and RNA as new binding targets of green tea catechins. J Biol Chem 2006; 281: 17446-17456.